Recent Clinical Results Revealed at ATTD 2024
At this year’s ATTD conference in Florence, RSP Systems shared recent findings from our latest clinical study, namely RSP-26, showcasing that non-invasive monitoring of glucose levels in people with type 2 diabetes is now possible and efficient following only a short initial calibration. Historically, the calibration stability and accuracy required for non-invasive glucose monitoring have […]
Publication of Clinical Results in ACS Sensors
Findings in clinical studies indicate that the combination of Raman Spectroscopy with multivariate data analysis, is the best fit for at-home non-invasive monitoring of glucose levels in people with diabetes. At RSP, we are not only demonstrating that Raman can measure glucose accurately and pain-free, but also that it provides stable calibration for a long […]
A Strong Partnership Announcement – Trumpf Photonics
RSP Systems is proud to announce that we have entered the new year with a strong partnership with Trumpf Photonics. Since the introduction of CGM more than 20 years ago, people with diabetes have searched for a more convenient solution to manage their disease. At RSP Systems, we are developing the world’s first non-invasive glucose […]
RSP Systems Joins The Soonicorn Club of Denmark
We are pleased to announce that RSP Systems A/S has been selected to be a part of the Soonicorn club of Denmark – an elite group of the most promising Denmark startups that have reached significant valuation milestones over the previous few years. RSP Systems was recognised as a Top Tech Minicorn in Denmark by […]
